Vaccine Guide

Navigating COVID-19 Vaccination in Fall 2025: A Practical Guide for Clinicians

Why Fall 2025 is different

COVID-19 vaccination is in a transition phase this season. In August, the FDA and CDC initially endorsed updated vaccine use focused on older adults and people with underlying conditions, a sharp departure from prior universal guidance.¹ However, at the September 2025 ACIP meeting, the committee voted to shift all COVID-19 vaccination to a shared clinical decision-making model for individuals aged 6 months and older.²

The American Academy of Pediatrics (AAP) had already taken the unusual step of publishing its own recommendations that diverged from the CDC, emphasizing broad pediatric coverage.³ Several states have also moved to expand vaccine access through standing orders, allowing pharmacists to vaccinate without individual prescriptions.⁴

This evolving landscape has created confusion for both providers and patients. This guide synthesizes federal, professional, and state-level updates to support clinical decision-making and patient communication.

Current CDC/ACIP/FDA recommendations

Who is included: As of September 2025, ACIP recommends that all individuals 6 months and older may be vaccinated under a shared clinical decision-making framework.² This means clinicians and patients (or caregivers) discuss risks, benefits, and personal circumstances before deciding.
Who benefits most: ACIP stressed that the greatest benefit remains for older adults (≥65 years), immunocompromised patients, and those with chronic medical conditions.²
FDA label vs ACIP: The FDA label for the updated 2025–26 vaccines still specifies older adults and high-risk groups, but ACIP’s broader recommendation ensures that all age groups may access vaccines without a prescription requirement.^1,2
Why the change? Officials cited widespread population immunity and the importance of individualized counseling. Critics caution that removing universal language could reduce uptake in groups that still benefit.¹

Professional society guidance

Medical societies have filled gaps left by federal policy:

AAP recommends vaccination for all infants 6–23 months, plus children 2–18 years with risk factors or whose caregivers request vaccination.³
ACOG continues to recommend vaccination during pregnancy and lactation, citing both maternal safety and antibody protection for infants.⁵
IDSA previously criticized the narrow FDA/CDC guidance, warning it “puts millions of lives at risk.”⁶ Their position aligns with the new ACIP framework in encouraging access beyond just high-risk groups.

Together, these positions suggest that standards of care in pediatrics, obstetrics, and infectious disease may still exceed FDA labeling while now being reinforced by ACIP’s decision-making model.

State policy landscape

State governments remain central to vaccine access.

Expanded access: States including New Jersey, New York, Minnesota, Maine, Arizona, Delaware, and others issued standing orders empowering pharmacists to vaccinate broadly, including healthy children and adults.^4,7,8
Prescription mandates: ACIP explicitly rejected a prescription requirement for COVID-19 vaccination.2 However, state statutes and pharmacy board regulations may still create variation.
Pharmacy access: CVS Health reports that, following ACIP’s vote, it is vaccinating without prescriptions in most states.⁴
Regional coalitions: West Coast states (California, Oregon, Washington, Hawaii) are coordinating recommendations aligned with professional society guidance.⁴

Providers should continue to monitor both state policies and pharmacy protocols, especially in border regions where patients may cross state lines for easier access.

Patient care and communication

Common patient questions

Patients are asking:

“Do I need the COVID vaccine this year?” Under ACIP’s shared decision-making recommendation, anyone 6 months and older is eligible. For older adults, pregnant individuals, patients who are immunocompromised, and anyone with chronic conditions, the answer remains strongly yes.² For younger healthy patients, vaccination is optional but safe, and clinicians should help weigh personal risks and preferences.²
“Can I get the COVID vaccine?” Yes. ACIP’s framework allows access without prescriptions, and most pharmacies can now provide vaccination directly, subject to state law.^2,4

Counseling high-risk groups

Older adults (65+): Universally encouraged.²
Chronic conditions: Diabetes, cardiovascular disease, chronic obstructive pulmonary disease, chronic kidney disease, obesity, HIV, and others remain priority groups.²
Immunocompromised: Eligible and may require individualized schedules.²
Pregnancy: Strongly recommended by ACOG, with maternal and neonatal protection.⁵

Addressing conflicting guidance

Conflicting messages have shifted: the main difference now is in emphasis. ACIP calls for individualized choice, while AAP and IDSA continue to advocate for stronger population-level uptake.^2,3,6 Clinicians should use shared decision-making to contextualize these positions for patients.

Access and cost

Insurance: Once ACIP recommendations are adopted into the CDC immunization schedule, vaccines recommended under shared decision-making are generally covered without cost-sharing under ACA preventive care requirements.^2,9
Uninsured: The CDC Bridge Access Program and local health departments continue to provide free or low-cost vaccination.⁴
Pharmacies: Most major chains now provide COVID, flu, and RSV vaccines at the same visit. Screening may be required, but prescriptions are no longer needed under ACIP policy.²

Coadministration

COVID-19, influenza, and RSV vaccines can still be administered together.⁵ Coadministration is particularly helpful for older adults and pregnant patients, simplifying fall vaccination visits.

Conclusion

For Fall 2025, COVID-19 vaccination guidance has shifted from rigid eligibility rules to a shared decision-making model. Clinicians should prioritize high-risk patients while supporting others who choose vaccination. By staying current with state protocols and offering evidence-based counseling, providers can help patients navigate confusion and maintain protection heading into respiratory virus season.

References: